Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-25-013478
Filing Date
2025-05-06
Accepted
2025-05-06 16:31:09
Documents
1
Period of Report
2025-05-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 5631
  Complete submission text file 0001127602-25-013478.txt   7086
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address
Frank Steven (Reporting) CIK: 0001583886 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23186 | Film No.: 25917772